Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Feb;52(2):171–175. doi: 10.1136/thx.52.2.171

Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask

S N Parkes, A D Bersten
PMCID: PMC1758492  PMID: 9059480

Abstract

BACKGROUND: Rates of fresh gas flow (FGF) commonly used when continuous positive airway pressure (CPAP) is delivered by face mask theoretically reduce the delivery and availability of therapeutic aerosols. As it may be hazardous for patients with acute respiratory failure to interrupt mask CPAP, the effects of CPAP on aerosol kinetics and bronchodilator efficacy were investigated. METHOD: The effect of CPAP at 10 cm H2O at a FGF rate of 50 l/min on the delivery of technetium labelled aerosol generated from a readily available jet nebuliser was measured using a bench model of spontaneous respiration. In a separate clinical study the bronchodilator responses to incremental doses of nebulised salbutamol were measured in nine stable asthmatic subjects in a random sequence of conventional nebulisation (control) or nebulisation whilst receiving CPAP via a tight fitting face mask. Each patient acted as his or her own control. RESULTS: CPAP significantly reduced total aerosol delivery to the face mask from 6.85 (1.52)% to 1.3 (0.37)% of the initial nebuliser charge. In the clinical study a significant bronchodilator response to nebulised salbutamol was seen during both conventional nebulisation and nebulisation whilst receiving CPAP by face mask. The shape of the dose-response curves and the magnitude of the total increase in the forced expiratory volume in one second (FEV1) was identical for CPAP and control conditions. CONCLUSIONS: Despite a reduction in aerosol presented to the proximal airway, the bronchodilator response to inhaled beta 2 agonists in stable asthmatic subjects was not affected when CPAP was delivered by face mask. Despite a high rate of FGF, nebulised beta 2 agonists are effective when administered in conjunction with CPAP delivered by face mask. 




Full Text

The Full Text of this article is available as a PDF (140.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bersten A. D., Holt A. W., Vedig A. E., Skowronski G. A., Baggoley C. J. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med. 1991 Dec 26;325(26):1825–1830. doi: 10.1056/NEJM199112263252601. [DOI] [PubMed] [Google Scholar]
  2. Bersten A. D., Rutten A. J., Vedig A. E., Skowronski G. A. Additional work of breathing imposed by endotracheal tubes, breathing circuits, and intensive care ventilators. Crit Care Med. 1989 Jul;17(7):671–677. doi: 10.1097/00003246-198907000-00015. [DOI] [PubMed] [Google Scholar]
  3. Bishop B., Hirsch J., Thursby M. Volume, flow, and timing of each breath during positive-pressure breathing in man. J Appl Physiol Respir Environ Exerc Physiol. 1978 Oct;45(4):495–501. doi: 10.1152/jappl.1978.45.4.495. [DOI] [PubMed] [Google Scholar]
  4. Braun S. R., Levy S. F. Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study. Am J Med. 1991 Oct 21;91(4A):28S–32S. doi: 10.1016/0002-9343(91)90259-z. [DOI] [PubMed] [Google Scholar]
  5. Gibney R. T., Wilson R. S., Pontoppidan H. Comparison of work of breathing on high gas flow and demand valve continuous positive airway pressure systems. Chest. 1982 Dec;82(6):692–695. doi: 10.1378/chest.82.6.692. [DOI] [PubMed] [Google Scholar]
  6. Higgins R. M., Stradling J. R., Lane D. J. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest. 1988 Oct;94(4):718–722. doi: 10.1378/chest.94.4.718. [DOI] [PubMed] [Google Scholar]
  7. Johnson M. A., Newman S. P., Bloom R., Talaee N., Clarke S. W. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest. 1989 Jul;96(1):6–10. doi: 10.1378/chest.96.1.6. [DOI] [PubMed] [Google Scholar]
  8. Katz J. A., Kraemer R. W., Gjerde G. E. Inspiratory work and airway pressure with continuous positive airway pressure delivery systems. Chest. 1985 Oct;88(4):519–526. doi: 10.1378/chest.88.4.519. [DOI] [PubMed] [Google Scholar]
  9. Katz J. A., Kraemer R. W., Gjerde G. E. Inspiratory work and airway pressure with continuous positive airway pressure delivery systems. Chest. 1985 Oct;88(4):519–526. doi: 10.1378/chest.88.4.519. [DOI] [PubMed] [Google Scholar]
  10. Lafortuna C. L., Minetti A. E., Mognoni P. Inspiratory flow pattern in humans. J Appl Physiol Respir Environ Exerc Physiol. 1984 Oct;57(4):1111–1119. doi: 10.1152/jappl.1984.57.4.1111. [DOI] [PubMed] [Google Scholar]
  11. Mercer T. T. Production of therapeutic aerosols; principles and techniques. Chest. 1981 Dec;80(6 Suppl):813–818. [PubMed] [Google Scholar]
  12. Newhouse M. T., Dolovich M. B. Control of asthma by aerosols. N Engl J Med. 1986 Oct 2;315(14):870–874. doi: 10.1056/NEJM198610023151406. [DOI] [PubMed] [Google Scholar]
  13. O'Doherty M. J., Thomas S. H., Page C. J., Treacher D. F., Nunan T. O. Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis. 1992 Aug;146(2):383–388. doi: 10.1164/ajrccm/146.2.383. [DOI] [PubMed] [Google Scholar]
  14. O'Riordan T. G., Greco M. J., Perry R. J., Smaldone G. C. Nebulizer function during mechanical ventilation. Am Rev Respir Dis. 1992 May;145(5):1117–1122. doi: 10.1164/ajrccm/145.5.1117. [DOI] [PubMed] [Google Scholar]
  15. Petrof B. J., Legaré M., Goldberg P., Milic-Emili J., Gottfried S. B. Continuous positive airway pressure reduces work of breathing and dyspnea during weaning from mechanical ventilation in severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1990 Feb;141(2):281–289. doi: 10.1164/ajrccm/141.2.281. [DOI] [PubMed] [Google Scholar]
  16. Phipps P. R., Gonda I. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest. 1990 Jun;97(6):1327–1332. doi: 10.1378/chest.97.6.1327. [DOI] [PubMed] [Google Scholar]
  17. SHARP J. T., GRIFFITH G. T., BUNNELL I. L., GREENE D. G. Ventilatory mechanics in pulmonary edema in man. J Clin Invest. 1958 Jan;37(1):111–117. doi: 10.1172/JCI103577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thomas S. H., O'Doherty M. J., Fidler H. M., Page C. J., Treacher D. F., Nunan T. O. Pulmonary deposition of a nebulised aerosol during mechanical ventilation. Thorax. 1993 Feb;48(2):154–159. doi: 10.1136/thx.48.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES